Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Vanda Pharmaceuticals Inc. VNDA

Full chart Compare
Set alert

Price alert · VNDA

All alert types
3.78 USD +0.02 (+0.67%)

Nov 4, 2026, 11:42 AM EST

3.73 Day range 3.91
3.64 52-week range 9.94
YTD
-57.20%
1 year
-13.22%

Revenue & Expenses

Other Income → Expenses: $12.52MExpenses → Selling, General & Admin: $237.95MExpenses → Research & Development: $109.27MExpenses → Other Operating Expenses: $7.01MExpenses → Income Tax: $81.83MGross Profit → Expenses: $203.06MRevenue → Gross Profit: $203.06MRevenue → Cost of Revenue: $13.04MNet Loss → Expenses: $220.47MOther Income$12.52MGross Profit$203.06MNet Loss$220.47MCost of Revenue$13.04MExpenses$436.06MSelling, General & Admin$237.95MResearch & Development$109.27MOther Operating Expenses$7.01MIncome Tax$81.83MRevenue$216.10M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Income statement

Full income statement How to read it
VNDA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
216.10M198.77M192.64M254.38M268.68M
203.06M187.46M177.84M230.10M243.05M
-151.17M-40.66M-13.95M6.33M42.16M
-220.47M-18.90M2.51M6.28M33.15M
-3.74-0.330.040.110.58

Balance sheet

Full balance sheet How to read it
VNDA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
84.85M102.32M135.82M135.03M52.07M
488.95M656.20M648.44M634.25M593.79M
161.76M117.66M103.53M107.05M88.86M
7.07M8.09M7.01M8.81M10.05M
327.19M538.55M544.91M527.20M504.93M

Cash flow

Full cash flow How to read it
VNDA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-109.44M-15.76M12.80M31.98M64.21M
94.86M-17.43M-12.06M49.92M-76.70M
-2.91M-155.00K0734.00K3.55M
-998.00K-490.00K-383.00K-679.00K-552.00K
-17.46M-33.51M792.00K82.91M-9.02M